Health
Breast cancer medication risk – Science Codex
New research led by Flinders University has found a link between beta-blockers and survival outcomes in some breast cancer patients.
Beta-blockers, commonly used to manage cardiovascular disease, were negatively associated with survival outcomes in patients with HER2 (Human Epidermal Growth Factor Receptor 2) positive advanced breast cancer, according to a new paper in the Frontiers In Oncology.
Using data collected from 2,777 patients in clinical trials, the study showed worse survival outco…
-
Noosa News19 hours agoWoman was watching keepers work when lion attacked, Darling Downs Zoo says
-
Noosa News18 hours agoWorking for someone else made it hard to care for my daughter. So I quit
-
General22 hours agoDeveloper warns wind energy capacity may not be ready by WA coal deadline
-
Noosa News21 hours agoStar Entertainment faces $36.5m blow if Queen’s Wharf deal flops